Wells Fargo & Company Health Catalyst, Inc. Transaction History
Wells Fargo & Company
- $407 Billion
- Q2 2024
A detailed history of Wells Fargo & Company transactions in Health Catalyst, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 26,218 shares of HCAT stock, worth $232,291. This represents 0.0% of its overall portfolio holdings.
Number of Shares
26,218
Previous 24,553
6.78%
Holding current value
$232,291
Previous $184,000
9.24%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding HCAT
# of Institutions
170Shares Held
50.1MCall Options Held
2.51MPut Options Held
1.8K-
Black Rock Inc. New York, NY5.43MShares$48.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.53MShares$40.1 Million0.0% of portfolio
-
First Light Asset Management, LLC Edina, MN3.96MShares$35.1 Million2.3% of portfolio
-
Impax Asset Management Group PLC2.55MShares$22.6 Million0.09% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.41MShares$21.4 Million0.01% of portfolio
About Health Catalyst, Inc.
- Ticker HCAT
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 54,723,400
- Market Cap $485M
- Description
- Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. Its offerings include data and analytics platform, a commercial-grade data and analytics platform for the healthcare sector; AI and data science, providing integration of AI into existing business intelligence tools, increasing analytics accura...